Financials
Financial year 2025
SOENEN-ABELOOS MED from Brugge, company number BE0722609616, closed financial year 2025 with a result of € 621,026 after tax. For that financial year SOENEN-ABELOOS MED recorded a gross margin of € 869,774 and equity of € 389,626. Compared with financial year 2024, the result moved from € 623,080 to € 621,026. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2026.
€ 389,626
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 621,026
Profit after tax over the fiscal year.
€ 391,234
▲ 71% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 573,080 paid out
92 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 37,441
▼ 27% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 142,857
▼ 20% vs 2024
€ 35,714 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 98
▼ 98% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,987
▲ € 30,261 vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 325,089 | € 480,993 | € 851,064 | € 869,774 | ▲ 2% |
| Profit after taxes | € 245,835 | € 349,623 | € 623,080 | € 621,026 | |
| Equity | € 273,619 | € 370,083 | € 341,680 | € 389,626 | ▲ 14% |
| Total debts | € 259,436 | € 294,156 | € 471,943 | € 755,053 | ▲ 60% |
| Cash | € 145,973 | € 305,911 | € 229,294 | € 391,234 | ▲ 71% |
| Retained profit | € 255,019 | € 351,483 | € 323,080 | € 371,026 | ▲ 15% |
| Dividend | € 311,765 | € 253,159 | € 651,483 | € 573,080 | ▼ 12% |
| Bank debt | € 0 | € 214,286 | € 178,571 | € 142,857 | ▼ 20% |
| Balance sheet total | € 533,055 | € 664,239 | € 813,623 | € 1,144,680 | ▲ 41% |
Key figures of SOENEN-ABELOOS MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOENEN-ABELOOS MED?
What happened at SOENEN-ABELOOS MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 621,026. filed late Source: NBB ↗
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 245,835 profit in 2022 to € 621,026 profit in 2025.
Paid € 438,404 in corporate taxes since 2022.
Best year ever: 2024, with € 623,080 profit.
Paid out € 1.8 million in dividends to the owners in total.
Management
Behind SOENEN-ABELOOS MED are Julie ABELOOS and Olivier SOENEN. It owns 15% of Holding MKA Zeeland itself.
Directors
According to the 2025 annual accounts
Julie ABELOOS
Director
Establishments
Establishment units
Physical locations of this company
Abelendreef 20
8200 Brugge
Vaubanstraat 73
8900 Ieper
Active since 11 March 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0722.609.616
- VAT number
- BE 0722.609.616
- Registered office
- Abelendreef 20, 8200 Brugge
- Names & denominations
- SOENEN-ABELOOS MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 March 2019
- Peppol
- Active · Active since 23 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten